Catherine Rowe
A5089061894- Glioma Diagnosis and Treatment
- RNA modifications and cancer
- Disaster Management and Resilience
- Pharmaceutical Practices and Patient Outcomes
- Electronic Health Records Systems
- Healthcare Policy and Management
- Brain Metastases and Treatment
- Pediatric health and respiratory diseases
- Primary Care and Health Outcomes
- Respiratory and Cough-Related Research
- Ear Surgery and Otitis Media
- Child and Animal Learning Development
- Cancer-related molecular mechanisms research
- Economic, Social, and Health Studies
- Chromatin Remodeling and Cancer
- Pain Management and Opioid Use
- Cancer Immunotherapy and Biomarkers
- Pediatric Pain Management Techniques
- Nursing Diagnosis and Documentation
- Intimate Partner and Family Violence
- Neuroblastoma Research and Treatments
- Data Quality and Management
- Pharmacological Effects and Toxicity Studies
- Global Health Care Issues
- CAR-T cell therapy research
The Royal Melbourne Hospital
2022
University of Bristol
2020
Brain Tumour Research
2020
North Bristol NHS Trust
2019
Peter MacCallum Cancer Centre
2017
Bond University
2011
Bangor University
2011
Royal Derby Hospital
2004
New York Academy of Medicine
2000
Infant high-grade gliomas appear clinically distinct from their counterparts in older children, indicating that histopathologic grading may not accurately reflect the biology of these tumors. We have collected 241 cases under 4 years age, and carried out histologic review, methylation profiling, custom panel, genome, or exome sequencing. After excluding tumors representing other established entities subgroups, we identified 130 to be part an "intrinsic" spectrum disease specific infant...
There is limited data on the efficacy of anti-programmed death 1 (PD-1) antibodies in patients (pts) with melanoma brain metastasis (BM), particularly those which are symptomatic. We retrospectively assessed pts BM treated PD-1 antibodies, nivolumab and pembrolizumab. Clinicopathologic treatment parameters were collected outcomes determined for intracranial (IC) response rate (RR) using a modified RECIST criteria, up to five IC target lesions used determine response, disease control (DCR)...
This paper reports on a national survey of Medicaid managed care plans sponsored by safety-net provider organizations that have mission service to low-income populations. We identified ninety-nine and obtained data from eighty them regarding their sponsorship, age size, relationships sponsors, practices, measures success. Most engage in active achieved at least some goals. However, 60 percent lost money 1997, economic trends been unfavorable.
Summary Introduction: Electronic medication administration record (eMAR) systems are promoted as a potential intervention to enhance safety in residential aged care facilities (RACFs). The purpose of this study was conduct an in-practice evaluation eMAR being piloted one Australian RACF before its roll out, and provide recommendations for system improvements. Methods: A multidisciplinary team conducted direct observations workflow (n=34 hours) the site community pharmacy. Semi-structured...
Health plans formed by safety-net providers serve large numbers of Medicaid beneficiaries. Through a series case studies, we examined the care management tools used leading plans. These do not rely on coercive, command-style managed care. They instead that emphasize partnership with providers: sharing data about practice patterns, using provider profiles and financial bonuses to encourage particular developing disease programs patient compliance treatment decisions make little effort shape....
Context: There is limited evidence on the role of objective parameters in influencing analgesic use cancer pain management.Objective: To investigate significance (age, male/female and performance status) opioid dose. Methods: We conducted a retrospective cross-sectional audit adult inpatients with metastatic at major centre from 1 January 2016 to 31 December 2018, who were prescribed slow release opioids for discharge. Main outcome measures demographics status), oral morphine equivalent...
<p>Supplementary Figures and Legends</p>
<div>Abstract<p>Infant high-grade gliomas appear clinically distinct from their counterparts in older children, indicating that histopathologic grading may not accurately reflect the biology of these tumors. We have collected 241 cases under 4 years age, and carried out histologic review, methylation profiling, custom panel, genome, or exome sequencing. After excluding tumors representing other established entities subgroups, we identified 130 to be part an “intrinsic” spectrum...
<p>Supplementary Figures and Legends</p>